IRF5 and autoimmune disease: Altogether, these results demonstrate that dysregulation of the IRF5-TRIM21 regulatory loop or expression of more stable isoforms in SLE patients could represent a novel mechanism of pathogenesis in SLE and possibly other autoimmune diseases.